MacroGenics
MGNX
#9145
Rank
โ‚น10.44 B
Marketcap
โ‚น165.09
Share price
2.23%
Change (1 day)
-39.77%
Change (1 year)

MacroGenics (MGNX) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚น18.38 Billion

According to MacroGenics's latest financial reports the company's total liabilities are โ‚น18.38 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

MacroGenics - Total liabilities on balance sheet (from 2012 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚น12.49 B2.9%
2023-12-31โ‚น12.13 B5.94%
2022-12-31โ‚น11.45 B60.97%
2021-12-31โ‚น7.11 B17.46%
2020-12-31โ‚น6.05 B3.79%
2019-12-31โ‚น5.83 B-6.45%
2018-12-31โ‚น6.24 B30.94%
2017-12-31โ‚น4.76 B64.98%
2016-12-31โ‚น2.88 B-5.36%
2015-12-31โ‚น3.05 B-8.44%
2014-12-31โ‚น3.33 B15.13%
2013-12-31โ‚น2.89 B-14.68%
2012-12-31โ‚น3.39 B-19.97%
2011-12-31โ‚น4.24 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Xencor
XNCR
โ‚น21.96 B 19.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น10.431 T 56,650.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น7.003 T 38,002.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น3.344 T 18,096.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น7.263 T 39,417.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น8.216 T 44,601.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น7.062 T 38,321.79%๐Ÿ‡บ๐Ÿ‡ธ USA